JP2009536623A5 - - Google Patents

Download PDF

Info

Publication number
JP2009536623A5
JP2009536623A5 JP2009507924A JP2009507924A JP2009536623A5 JP 2009536623 A5 JP2009536623 A5 JP 2009536623A5 JP 2009507924 A JP2009507924 A JP 2009507924A JP 2009507924 A JP2009507924 A JP 2009507924A JP 2009536623 A5 JP2009536623 A5 JP 2009536623A5
Authority
JP
Japan
Prior art keywords
alkyl
group
compound
compound according
glaucoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009507924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009536623A (ja
Filing date
Publication date
Priority claimed from US11/409,868 external-priority patent/US7718830B2/en
Priority claimed from US11/409,570 external-priority patent/US7612101B2/en
Priority claimed from US11/409,871 external-priority patent/US7618966B2/en
Application filed filed Critical
Priority claimed from PCT/US2007/067267 external-priority patent/WO2007127711A2/en
Publication of JP2009536623A publication Critical patent/JP2009536623A/ja
Publication of JP2009536623A5 publication Critical patent/JP2009536623A5/ja
Pending legal-status Critical Current

Links

JP2009507924A 2006-04-24 2007-04-24 眼圧降下剤としてのアブノーマル・カンナビジオール化合物 Pending JP2009536623A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/409,868 US7718830B2 (en) 2006-04-24 2006-04-24 Abnormal cannabidiols as agents for lowering intraocular pressure
US11/409,570 US7612101B2 (en) 2006-04-24 2006-04-24 Abnormal cannabidiols as agents for lowering intraocular pressure
US11/409,871 US7618966B2 (en) 2006-04-24 2006-04-24 Abnormal Cannabidiols as agents for lowering intraocular pressure
PCT/US2007/067267 WO2007127711A2 (en) 2006-04-24 2007-04-24 Abnormal cannabidiols as agents for lowering intraocular pressure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013228274A Division JP2014058536A (ja) 2006-04-24 2013-11-01 眼圧降下剤としてのアブノーマル・カンナビジオール化合物

Publications (2)

Publication Number Publication Date
JP2009536623A JP2009536623A (ja) 2009-10-15
JP2009536623A5 true JP2009536623A5 (cg-RX-API-DMAC7.html) 2010-06-17

Family

ID=38229040

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009507924A Pending JP2009536623A (ja) 2006-04-24 2007-04-24 眼圧降下剤としてのアブノーマル・カンナビジオール化合物
JP2013228274A Pending JP2014058536A (ja) 2006-04-24 2013-11-01 眼圧降下剤としてのアブノーマル・カンナビジオール化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013228274A Pending JP2014058536A (ja) 2006-04-24 2013-11-01 眼圧降下剤としてのアブノーマル・カンナビジオール化合物

Country Status (7)

Country Link
US (2) US7968711B2 (cg-RX-API-DMAC7.html)
EP (2) EP2010165A2 (cg-RX-API-DMAC7.html)
JP (2) JP2009536623A (cg-RX-API-DMAC7.html)
AU (1) AU2007244978B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0710732A2 (cg-RX-API-DMAC7.html)
CA (3) CA2823724A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007127711A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050282902A1 (en) * 2004-06-22 2005-12-22 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7618966B2 (en) * 2006-04-24 2009-11-17 Allergan, Inc. Abnormal Cannabidiols as agents for lowering intraocular pressure
WO2011006099A1 (en) * 2009-07-10 2011-01-13 Northeastern University Angiogenic resorcinol derivatives
JP2022522534A (ja) 2019-04-02 2022-04-19 アリゴス セラピューティクス インコーポレイテッド Prmt5を標的にする化合物
WO2021007661A1 (en) * 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
CA3150642A1 (en) 2019-09-09 2021-03-18 Kamaluddin Abdur-Rashid CANNABINOID DERIVATIVES, PRECURSORS AND USES
US20260193222A1 (en) * 2022-12-02 2026-07-09 Benethera (Shaoxing) Biotechnology Co., Ltd. Compound and use thereof in treatment of treg-related diseases

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE607934A (cg-RX-API-DMAC7.html) 1960-09-09
US3281424A (en) 1964-04-15 1966-10-25 Geigy Chem Corp Certain pyridobenzodiazepine derivatives
PL122765B1 (en) * 1977-09-13 1982-08-31 Method of manufacture of novel derivatives of cycloalkanes
SE431085B (sv) * 1977-09-13 1984-01-16 Pfizer 3-(2-hydroxi-4-(substituerade)fenyl)cykloalkanoner och -cykloalkanoder och vissa derivat derav till anvendning for farmakologiska och medicinska endamal
US4529732A (en) 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
GB8329531D0 (en) 1983-11-04 1983-12-07 Ici America Inc Pyrazolopyridine cycloalkanones
YU134686A (en) 1985-07-30 1988-02-29 Nissan Chemical Ind Ltd Process for preparing new derivatives 3-(2h)-pyridazinone
GB8711525D0 (en) 1987-05-15 1987-06-17 Shell Int Research Oximino ether compounds
GB8722838D0 (en) 1987-09-29 1987-11-04 Shell Int Research Oximino ether compounds
EP0492904A1 (en) 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted benzene derivatives for use in the treatment of glaucoma
US6646001B2 (en) * 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
WO2000056702A1 (en) * 1999-03-22 2000-09-28 Pfizer Inc. Resorcinol derivatives
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
JP3950046B2 (ja) * 2000-09-21 2007-07-25 ファイザー・プロダクツ・インク レゾルシノール誘導体
AU2002322466B2 (en) * 2001-07-11 2007-08-30 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
AP1822A (en) * 2002-02-14 2008-01-30 Pharmacia Corp Substituted pyridinones as modulators of P38 MAP kinase.
US6863897B2 (en) * 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US7285687B2 (en) * 2002-04-25 2007-10-23 Virginia Commonwealth University Cannabinoids
MXPA05011292A (es) 2003-04-24 2006-01-24 Mallinckrodt Inc Proceso para la preparacion de (+)-p-menta-2,8-dien-1-ol.
WO2005007632A1 (en) 2003-07-18 2005-01-27 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
CN1964627B (zh) 2004-06-04 2011-10-19 华盛顿大学 治疗神经病变的方法和组合物
US20050282902A1 (en) * 2004-06-22 2005-12-22 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US20050282912A1 (en) 2004-06-22 2005-12-22 June Chen Abnormal cannabidiols as neuroprotective agents for the eye
US20050282913A1 (en) 2004-06-22 2005-12-22 June Chen Abnormal cannabidiols as agents for lowering intraocular pressure
JP2008503577A (ja) 2004-06-22 2008-02-07 アラーガン、インコーポレイテッド 眼圧を降下するためのアブノーマル・カンナビジオール化合物
AU2006269459B2 (en) * 2005-07-07 2013-02-07 Sirtris Pharmaceuticals, Inc. Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
WO2007014226A2 (en) 2005-07-26 2007-02-01 The Board Of Trustees Of The University Of Illinois Compounds for the treatment of neurodegeneration and stroke
US20080282902A1 (en) 2007-01-05 2008-11-20 Dayton Douglas C Automatic cooking appliance shutoff apparatus

Similar Documents

Publication Publication Date Title
CA2858787C (en) Prodrugs of tertiary amine compounds
ES2928162T3 (es) Composiciones, formulaciones y métodos para tratar enfermedades oculares
KR102576011B1 (ko) 암의 치료를 위한 조합 요법
JP7546027B2 (ja) ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
AR056155A1 (es) Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
JP2010513319A5 (cg-RX-API-DMAC7.html)
JP2013523821A5 (cg-RX-API-DMAC7.html)
JP2005523316A5 (cg-RX-API-DMAC7.html)
CN106562962A (zh) 用于治疗眼部水肿、新血管形成及相关疾病的组合物和方法
JP2010514832A5 (cg-RX-API-DMAC7.html)
DK2888239T3 (en) REDUCED CENTRAL CORCHET THICKENING USING HYDROFILE ESTER PRODUGS OF BETA-CHLORCYCLOPENTANE
JP2008110984A5 (cg-RX-API-DMAC7.html)
RU2371444C1 (ru) ФУРО- И ТИЕНО[2,3-b]-ХИНОЛИН-2-КАРБОКСАМИДЫ, СПОСОБ ПОЛУЧЕНИЯ И ПРОТИВОТУБЕРКУЛЕЗНАЯ АКТИВНОСТЬ
RU2013154733A (ru) Производные бензоциклогептенуксусной кислоты
JP2020527540A5 (cg-RX-API-DMAC7.html)
KR102544132B1 (ko) 항종양 활성을 갖는 화합물
JP2005519885A5 (cg-RX-API-DMAC7.html)
JP2004534781A5 (cg-RX-API-DMAC7.html)
JP6495379B2 (ja) 水性の組成物
JP2005536531A5 (cg-RX-API-DMAC7.html)
JP2010514733A5 (cg-RX-API-DMAC7.html)
JP2019534296A5 (cg-RX-API-DMAC7.html)
JP2006501245A5 (cg-RX-API-DMAC7.html)
DK3107906T3 (en) REDUCED CENTRAL CORNER MAP THICKNESS USING HYDROFILE ESTER PRODRUGS OF BETA-CHLORCYCLOPENTANE
JP2004529177A5 (cg-RX-API-DMAC7.html)